These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16141975)

  • 21. Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events.
    Hankey GJ; Eikelboom JW
    Lancet Neurol; 2010 Mar; 9(3):273-84. PubMed ID: 20170841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
    Davis SM; Donnan GA
    N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
    [No Abstract]   [Full Text] [Related]  

  • 23. Antithrombotic selection and risk factor management in ischemic stroke and transient ischemic attack.
    Katz BS; Flemming KD
    Neurosurg Focus; 2014 Jan; 36(1):E10. PubMed ID: 24380476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?
    Johnson P; Rosewell M; James MA
    Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral Anticoagulant Use in Atrial Fibrillation-Associated Ischemic Stroke: A Retrospective, Multicenter Survey in Northwestern China.
    Zhang J; Yang XA; Zhang Y; Wei JY; Yang F; Gao H; Jiao WW; Sun XL; Gao Q; Jiang W
    J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):125-131. PubMed ID: 27645612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Primary and secondary prevention of ischemic stroke].
    Awada A
    J Med Liban; 2011; 59(4):213-9. PubMed ID: 22746010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.
    Yu HC; Tsai YF; Chen MC; Yeh CH
    Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in medical and surgical therapy for stroke prevention between leading experts in North America and Western Europe.
    Masuhr F; Busch M; Einhäupl KM
    Stroke; 1998 Feb; 29(2):339-45. PubMed ID: 9472871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulant treatment in patients with atrial fibrillation and ischemic stroke.
    Brunner Frandsen NS; Andersen AD; Ashournia H; Brandslund I; Kjærsgaard JO; Vilholm OJ
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1120-5. PubMed ID: 25881779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
    Chalmers J; MacMahon S
    J Hypertens Suppl; 2003 Jun; 21(5):S9-14. PubMed ID: 12953850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombotic therapy after acute ischemic stroke in patients with atrial fibrillation.
    McGrath ER; Kapral MK; Fang J; Eikelboom JW; Conghaile Aó; Canavan M; O'Donnell MJ;
    Stroke; 2014 Dec; 45(12):3637-42. PubMed ID: 25378422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006.
    Béjot Y; Ben Salem D; Osseby GV; Couvreur G; Durier J; Marie C; Cottin Y; Moreau T; Giroud M
    Neurology; 2009 Jan; 72(4):346-53. PubMed ID: 19171832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.
    Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P
    Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. To Treat or Not to Treat: Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation.
    Appelros P; Farahmand B; Terént A; Åsberg S
    Stroke; 2017 Jun; 48(6):1617-1623. PubMed ID: 28487335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A score for paroxysmal atrial fibrillation in acute ischemic stroke.
    Naess H; Andreassen UW; Thomassen L; Kvistad CE
    Int J Stroke; 2018 Jul; 13(5):496-502. PubMed ID: 28762898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
    J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
    J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.